Kincell Bio

Kincell Bio

制药业

Gainesville,Florida 3,547 位关注者

Engineering cells into therapies.

关于我们

Kincell is a technology-forward contract development and manufacturing organization (CDMO) that streamlines analytical development, process development, CMC consulting and GMP cell therapy manufacturing. Our focus is on developing and manufacturing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs. For more information, please visit our website at www.kincellbio.com.

所属行业
制药业
规模
11-50 人
总部
Gainesville,Florida
类型
私人持股
创立
2023
领域
non-viral delivery technologies、early phase cell therapy、manufacturing GMP grade和CMC support

地点

动态

相似主页

融资

Kincell Bio 共 1 轮

上一轮

A 轮

US$36,000,000.00

Crunchbase 上查看更多信息